cataract risk at low radiation dose seeing is believing
play

Cataract risk at low radiation dose: Seeing is believing 1 - PowerPoint PPT Presentation

Cataract risk at low radiation dose: Seeing is believing 1 Cataract risk at low radiation dose: Seeing is believing Paul Jonkergouw Radboud University Nijmegen 2 ICRP recommendations (2007) 3 ICRP recommendations (2007) 4 5 ICRP


  1. Cataract risk at low radiation dose: Seeing is believing 1

  2. Cataract risk at low radiation dose: Seeing is believing Paul Jonkergouw Radboud University Nijmegen 2

  3. ICRP recommendations (2007) 3

  4. ICRP recommendations (2007) 4

  5. 5

  6. ICRP statement on tissue reactions → lens How come 6

  7. 1 Content 1. Lens structure 2 2. Cataract / cataractogenesis 3. Radiosensitivity of the lens 4. Lens effects, recent literature 5. O’CLOC study results 3 4 5 7

  8. Lens structure development, embryonic phase 8

  9. Lens structure adult phase anterior posterior 9

  10. Lens structure adult phase anterior posterior Frederique M.D. Tholozan , Roy A. Quinlan Lens cells: More than meets the eye The International Journal of Biochemistry & Cell Biology Volume 39, Issue 10 2007 1754 - 1759 10

  11. Lens structure fibre cells onion-like orientation 11

  12. Cataract • Nuclear cataract (NC) → 70% • Cortical cataract (AC) → 25% • Posterior subcapsular cataract (PSC) → 5% posterior subcapsular cataract (PSC) 12

  13. Cataractogenesis crystallins ! Frederique M.D. Tholozan , Roy A. Quinlan Lens cells: More than meets the eye The International Journal of Biochemistry & Cell Biology Volume 39, Issue 10 2007 1754 - 1759 13

  14. Crystallins • member of small Hsp • in human lens: CRYaA : CRYaB = 3:1 • CRYaA found mainly in lens • lens protein concentration: 450 mg/ml → referactive index → tranparency • lens fibre cell: 90% crystallins • main function: chaperone properties suppressing non-specific CRYaA aggregation due to unfolde/denatured proteins target molecules / mechanism ? CRYaB 14

  15. Radiosensitivity A-bomb survivors 0.1 0.8 Gy 0.1 Gy threshold or non- threshold ? Roy E. Shore, Kazuo Neriishi, Eiji Nakashima Epidemiological Studies of Cataract Risk at Low to Moderate Radiation Doses: (Not) Seeing is Believing Radiation Research 174, 889-894 (2010) 15

  16. Radiosensitivity recent literature E.A. Ainsbury, S.D Bouffler, W. Dörr, J. Graw, C.R. Muirhead, A.A. Edwards, J. Cooper Radiation Cataractogenesis: A Review of Recent Studies Radiation Research 172(1), 1-9 (2009) 16

  17. Occupational risk interventional cardiology • Latin America (Vano et al. 2010): – case control: 116 exposed, 93 non-exposed – median lens dose: • cardiologist: 6 Sv • assistent: 1,5 Sv dose- – 38% vs. 12% PSC (RR= 3.2, p<0.005) dependent – 21% nurses/technicians had PSC • Malaysia (Ciraj Bjelac et al. 2011): – 52% vs. 9% PSC (RR= 5.7, p<0.05) 17

  18. O’CLOC study (France) occupational cataract, IC courtesy Sophie Jacob, IRSN France 18

  19. O’CLOC study (France) occupational cataract, IC Cumulative lens dose* Mean doses ( µ Sv/procedure) Mean ± SD p-val. (mSv) 423 ± 359 Coronarography 46 All cardiologists (min 25; max 1658) Angioplasty 102 455 ± 373 CICs (min 29; max 1658) PM or DEF: implantation 59 p=0.09 343 ± 308 Electrophysiologists PM or DEF: resynchronization 236 (min 25; max 1650) RF Ablation except AF 65 RF Ablation of AF 130 * retrospectively assessed from ORAMED dataset courtesy Sophie Jacob, IRSN France 19

  20. O’CLOC study (France) occupational cataract, IC mean annual dose courtesy Sophie Jacob, IRSN France 20

  21. O’CLOC study (France) occupational cataract, IC Interventional cardiologists Unexposed group N=106 N=99 % (95% CI) % (95% CI) Nuclear 60% (51 - 69) 69% (60 - 78) Cortical 23% (15 - 31) 29% (20 - 38) 17 %(10 - 24) 5% (1 - 9) Posterior Subcapsular OR adjusted= 3.8 (1.3 – 11.4) courtesy Sophie Jacob, IRSN France 21

  22. O’CLOC study (France) occupational cataract, IC 22

  23. Conclusion ICRP recommendations revisited 20 mSv 23

  24. 24

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend